Mithramycin forms a stable dimeric complex by chelating with Fe(II): DNA-interacting characteristics, cellular permeation and cytotoxicity.
Mith (mithramycin) forms a 2:1 stoichiometry drug-metal complex through the chelation with Fe(II) ion as studied using circular dichroism spectroscopy. The binding affinity between Mith and Fe(II) is much greater than other divalent metal ions, including Mg(II), Zn(II), Co(II), Ni(II) and Mn(II). The [(Mith)2-Fe(II)] complex binds to DNA and induces a conformational change of DNA. Kinetic analysis of surface plasmon resonance studies revealed that the [(Mith)2-Fe(II)] complex binds to DNA duplex with higher affinity compared with the [(Mith)2-Mg(II)] complex. A molecular model of the Mith-DNA-Metal(II) complex is presented. DNA-break assay showed that the [(Mith)2-Fe(II)] complex was capable of promoting the one-strand cleavage of plasmid DNA in the presence of hydrogen peroxide. Intracellular Fe(II) assays and fluorescence microscopy studies using K562 indicated that this dimer complex maintains its structural integrity and permeates into the inside of K562 cells, respectively. The [(Mith)2-Fe(II)] complex exhibited higher cytotoxicity than the drug alone in some cancer cell lines, probably related to its higher DNA-binding and cleavage activity. Evidences obtained in this study suggest that the biological effects caused by the [(Mith)2-Fe(II)] complex may be further explored in the future.
Hou
Ming-Hon
MH
Institute of Biological Chemistry, Academia Sinica Taipei, 115 Taiwan.
Wang
Andrew H-J
AH
D000903:Antibiotics, Antineoplastic / Q000737:chemistry* / Q000378:metabolism / Q000633:toxicity*; D001483:Base Sequence; D002413:Cations, Divalent / Q000737:chemistry; D045744:Cell Line, Tumor; D002463:Cell Membrane Permeability; D002942:Circular Dichroism; D004247:DNA / Q000737:chemistry* / Q000378:metabolism; D005296:Ferrous Compounds / Q000737:chemistry* / Q000378:metabolism / Q000633:toxicity*; D006801:Humans; D007502:Iron Chelating Agents / Q000737:chemistry; D020014:K562 Cells; D008670:Metals / Q000737:chemistry; D008958:Models, Molecular; D009690:Nucleic Acid Conformation; D010957:Plasmids / Q000378:metabolism; D008926:Plicamycin / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000378:metabolism / Q000633:toxicity*; D020349:Surface Plasmon Resonance
D000903:Antibiotics, Antineoplastic; D002413:Cations, Divalent; D005296:Ferrous Compounds; D007502:Iron Chelating Agents; D008670:Metals; C497846:bis(mithromycin)iron(II); D004247:DNA; D008926:Plicamycin
Blood. 2002 Jul 15;100(2):666-76
12091363
Blood. 1998 Aug 15;92(4):1384-9
9694727
Biochemistry. 1993 Jul 6;32(26):6588-604
8329387
Adv Pharmacol Chemother. 1975;12(0):1-30
125531
Nucleic Acids Res. 1985 Dec 20;13(24):8695-714
2934687
J Med Chem. 1999 Jul 29;42(15):2844-51
10425093
Blood. 1999 Sep 15;94(6):2128-34
10477743
J Neurosci. 2004 Nov 17;24(46):10335-42
15548647
J Mol Biol. 1993 Jun 5;231(3):753-67
8515449
Med Res Rev. 2003 Nov;23(6):697-762
12939790
Nucleic Acids Res. 2002 Nov 15;30(22):4910-7
12433994
J Mol Biol. 1995 Sep 1;251(5):674-89
7666419
Biochemistry. 1997 Feb 25;36(8):2291-9
9047331
Am J Physiol. 1995 Jun;268(6 Pt 1):C1354-61
7611353
Nucleic Acids Res. 2004;32(6):2000-7
15064359
J Am Chem Soc. 2003 May 14;125(19):5745-53
12733914
J Bone Joint Surg Am. 1972 Dec;54(8):1730-6
4265871
Oncogene. 1995 Jun 15;10(12):2323-30
7784080
Nucleic Acids Res. 2001 Dec 15;29(24):5121-8
11812845
Biopolymers. 2000 Aug;54(2):104-14
10861371
J Urol. 1972 Mar;107(3):429-32
4258726
Nucleic Acids Res. 2004;32(7):2214-22
15107489
Biopolymers. 1990 Feb 15;29(3):481-9
2110008
J Biol Chem. 1995 Oct 13;270(41):24209-15
7592626
Oncology. 1973;28(2):147-63
4270380
Free Radic Biol Med. 2002 Oct 15;33(8):1037-46
12374615
Anal Biochem. 1996 Jan 15;233(2):221-7
8789722
Biochemistry. 1995 Jan 31;34(4):1376-85
7827085
Blood. 2003 Aug 15;102(4):1276-81
12738678
Blood. 2001 Aug 1;98(3):842-50
11468187
Biochem Biophys Res Commun. 1989 Apr 28;160(2):517-24
2524195
Biochimie. 1995;77(9):729-38
8789464
Biochemistry. 2003 Oct 14;42(40):11751-61
14529286
Pharmacol Ther. 1999 Sep;83(3):181-215
10576292
J Med Chem. 2003 Apr 24;46(9):1683-9
12699386
Eur J Biochem. 1991 Jun 1;198(2):333-8
1828228
FEBS Lett. 1990 May 7;264(1):100-4
2140099
Biochem Biophys Res Commun. 1990 Dec 14;173(2):689-96
2148084
Annu Rev Biochem. 1971;40:775-810
4107711
Acta Crystallogr D Biol Crystallogr. 1996 Jan 1;52(Pt 1):57-64
15299726
Biochemistry. 1983 May 10;22(10):2373-7
6222762